Evaluation for the efficacy of TAZ/PIPC for cholangitis after choledochojejunostomy

Evaluation for the efficacy of TAZ/PIPC for cholangitis after choledochojejunostomy - Evaluation for the efficacy of TAZ/PIPC for cholangitis after choledochojejunostomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012168

Enrollment

Registered

2013-11-01

Start date

2013-06-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholangitis after choledocojejunostomy

Interventions

TAZ/PIPC carbapenem antibiotics

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: cholangitis after choledochojejunostomy

Exclusion criteria

Exclusion criteria: 1) allergy for Penicillin 2) Infectious mononucleosis 3) Sodium valproate remedy 4) other therapy 5) pregnancy 6) severe cardiovascular, liver and renal disfunction 7) Past enrolled patients 8) severe mental disorder 9) others

Design outcomes

Primary

Measure	Time frame
clinical effect	—

Secondary

Measure	Time frame
Bacteriological effect	—

Countries

Japan

Contacts

Public ContactHideyoshi Toyokawa

Kansai Medical University Department of Surgery

toyokawh@hirakata.kmu.ac.jp072-804-0101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026